Boston Trust Walden Corp Buys New Stake in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Boston Trust Walden Corp purchased a new position in Axcelis Technologies, Inc. (NASDAQ:ACLS) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 506,427 shares of the semiconductor company’s stock, valued at approximately $53,099,000. Boston Trust Walden Corp owned approximately 1.56% of Axcelis Technologies as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ACLS. Signaturefd LLC grew its holdings in shares of Axcelis Technologies by 348.9% in the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 164 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Axcelis Technologies by 223.8% in the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock worth $39,000 after buying an additional 188 shares during the last quarter. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Axcelis Technologies during the 2nd quarter valued at about $39,000. Isthmus Partners LLC lifted its holdings in shares of Axcelis Technologies by 87.3% in the 2nd quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock valued at $47,000 after acquiring an additional 15,507 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in Axcelis Technologies in the second quarter worth about $69,000. Hedge funds and other institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Trading Down 0.0 %

NASDAQ:ACLS traded down $0.04 during midday trading on Friday, hitting $89.89. The stock had a trading volume of 552,976 shares, compared to its average volume of 627,850. The stock has a 50-day moving average of $101.76 and a 200 day moving average of $114.20. The company has a market capitalization of $2.92 billion, a price-to-earnings ratio of 11.87, a PEG ratio of 3.02 and a beta of 1.58. Axcelis Technologies, Inc. has a one year low of $88.89 and a one year high of $158.61. The company has a quick ratio of 3.26, a current ratio of 4.42 and a debt-to-equity ratio of 0.05.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings results on Wednesday, July 31st. The semiconductor company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.37 by $0.18. Axcelis Technologies had a return on equity of 27.35% and a net margin of 21.54%. The firm had revenue of $256.51 million for the quarter, compared to analyst estimates of $250.06 million. During the same quarter last year, the firm posted $1.86 earnings per share. The business’s revenue for the quarter was down 6.4% on a year-over-year basis. As a group, sell-side analysts forecast that Axcelis Technologies, Inc. will post 6.05 EPS for the current year.

Insider Transactions at Axcelis Technologies

In other news, Director Jorge Titinger sold 6,086 shares of Axcelis Technologies stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $109.98, for a total value of $669,338.28. Following the transaction, the director now directly owns 5,891 shares in the company, valued at approximately $647,892.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.43% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on ACLS shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a research note on Friday, August 2nd. Bank of America boosted their price objective on shares of Axcelis Technologies from $125.00 to $150.00 and gave the company a “neutral” rating in a research report on Wednesday, July 10th. B. Riley lowered their target price on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating for the company in a report on Friday, August 2nd. DA Davidson boosted their target price on Axcelis Technologies from $150.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, July 15th. Finally, Benchmark reduced their price target on Axcelis Technologies from $180.00 to $175.00 and set a “buy” rating on the stock in a report on Friday, August 2nd. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.